On July 16, 2025, Mizuho analyst Anthony Petrone issued a report on DexCom (DXCM, Financial), maintaining an "Outperform" rating and raising the price target from $95.00 to $100.00. This adjustment represents a 5.26% increase in the price target, highlighting continued confidence in the potential performance of DXCM.
The analysis reflects Mizuho's positive outlook on DXCM, driven by promising growth prospects and market presence. The decision to maintain the "Outperform" rating indicates an expectation that DXCM will continue to perform better than the general market or industry sector over the coming period.
Investors may consider this revised target as a signal of DexCom's (DXCM, Financial) robust outlook and potential for value appreciation within the healthcare technology space. The report offers insights into DXCM's strategic positioning and market strategy as observed by expert analysts at Mizuho.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 26 analysts, the average target price for DexCom Inc (DXCM, Financial) is $100.09 with a high estimate of $115.00 and a low estimate of $85.00. The average target implies an upside of 18.05% from the current price of $84.78. More detailed estimate data can be found on the DexCom Inc (DXCM) Forecast page.
Based on the consensus recommendation from 28 brokerage firms, DexCom Inc's (DXCM, Financial) average brokerage recommendation is currently 1.7, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for DexCom Inc (DXCM, Financial) in one year is $169.00, suggesting a upside of 99.34% from the current price of $84.78. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the DexCom Inc (DXCM) Summary page.
